Prohibited substances in class (A) include the following examples:
amineptine
amiphenazole
amphetamines
bromantan, caffeine
carphedon
cocaine
ephedrines**
fencamfamin
formoterol ***
mesocarb
pentetrazol
pipradrol
salbutamol***
salmeterol***
terbutaline***
and related substances.
* For caffeine the definition of a positive is a concentration in urine greater than 12 micrograms per millilitre.
** For cathine, the definition of a positive is a concentration in urine greater than 5 micrograms per millilitre. For ephedrine and methylephedrine, the definition of a positive is a concentration in urine greater than 10 micrograms per millilitre. For phenylpropanolamine and pseudoephedrine, the definition of a positive is a concentration in urine greater than 25 micrograms per millilitre.
*** Permitted by inhaler only to prevent and/or treat asthma and exercise-induced asthma.. Written notification by a respiratory or team physician that the athlete has asthma and/or exercise-induced asthma, is necessary to the relevant medical authority prior to competition.. At the Olympics Games, athletes who request permission to inhale a permitted beta agonist will be assessed by an independent medical panel.
NOTE: All imidazole preparations are acceptable for topical use. Vasoconstrictors may be administered with local anaesthetic agents. Topical preparations (e.g. nasal, ophthalmological, rectal) of adrenaline and phenylephrine are permitted.
NOTE: codeine, dextromethorphan, dextropropoxyphene, dihydrocodeine, diphenoxylate, ethylmorphine, pholcodine, propoxyphene and tramadol are permitted.
Evidence obtained from metabolic profiles and/or isotopic ratio measurements may be used to draw definitive conclusions.
* The presence of a testosterone (T) to epitestostrone (E) ratio greater than six (6) to one (1) in the urine of a competitor constitutes an offence unless there is evidence that this ratio is due to a physiological or pathological condition, e.g. low epitestosterone excretion, androgen producing tumour, enzyme deficiencies.
In the case of T/E greater than 6, it is mandatory that the relevant medical authority conducts an investigation before the sample is declared positive. A full report will be written and will include a review of previous tests, subsequent tests and any results of endocrine investigations. In the event that previous tests are not available, the athlete should be tested unannounced at least once per month for three months. The results of these investigations should be included in the report. Failure to co-operate in the investigations will result in declaring the sample positive.
Beta-2 agonists
bambuterol
clenbuterol
fenoterol
formoterol*
reproterol
salbutamol*
salmeterol*
terbutaline*
... and related substances.
*Authorized by inhalation as described in Article (I.A.). For salbutamol the definition of a positive under the anabolic agent category is a concentration in urine greater than 1000 nanograms per millilitre.
* Prohibited by intravenous injection.
The presence of an abnormal concentration of an endogenous hormone in class (E)or its diagnostic marker(s) in the urine of a competitor constitutes an offence unless it has been proven to be due to a physiological or pathological condition.
